1. Home
  2. UAMY vs CADL Comparison

UAMY vs CADL Comparison

Compare UAMY & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

HOLD

Current Price

$5.30

Market Cap

955.8M

Sector

Industrials

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$12.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAMY
CADL
Founded
1968
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
955.8M
1.0B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
UAMY
CADL
Price
$5.30
$12.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$9.44
$19.00
AVG Volume (30 Days)
7.5M
1.2M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$39,257,708.00
$125,000.00
Revenue This Year
$219.89
N/A
Revenue Next Year
$104.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
162.80
N/A
52 Week Low
$4.36
$4.35
52 Week High
$19.71
$14.00

Technical Indicators

Market Signals
Indicator
UAMY
CADL
Relative Strength Index (RSI) 47.97 51.44
Support Level $4.76 $4.91
Resistance Level $5.78 $14.00
Average True Range (ATR) 0.37 0.70
MACD 0.06 -0.17
Stochastic Oscillator 66.67 12.37

Price Performance

Historical Comparison
UAMY
CADL

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: